Status and phase
Conditions
Treatments
About
The primary objective of this prospective, Randomized, Controlled, Multicentre, Open Study is to investigate the inhibition of restenosis by the Paclitaxel-eluting Percutaneous transluminal angioplasty (PTA) balloon Freeway versus PTA alone in the treatment of de-novo occluded, stenotic or reoccluded, restenotic superficial femoral (SFA) or popliteal arteries.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
280 participants in 2 patient groups
Loading...
Central trial contact
Beatriz Fernandez, PhD; Rembert Pogge von Strandmann, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal